FZD2 and neoplasm: Of note, MN1 exerts a pro-tumor effect through the XIST/miR-15a-5p/MN1/FZD2 signaling axis, and its significantly high expression is observed in female patients with poor prognosis, which may be an important molecular basis for the gender difference in BLCA (70).